US Proton Therapy Market will Attain Revenue of Around US$ 1 Billion US Proton Therapy Market 2022

US Proton Therapy Market will Attain
Revenue of Around US$ 1 Billion by 2022:
Radiant Insights, Inc
“According to the report, by 2022, the US will have
38 proton therapy centers. Consequently, the market
will attain revenue of around US$ 1 Billion by 2022,
growing at a CAGR of over 16% during the forecast
period (2015-2022).”
Owing to the growth in cancer incidences in the US, various technologically advanced therapies are
now being introduced in the country. One such advanced technology is the Proton Therapy.
Previously, the access to proton therapy is limited for a vast population owing to a low number of
proton therapy centers, and barriers to insurance coverage for those procedures. Hence, many
research institutions and hospitals have now started investing in proton therapy to make it more
accessible to patients. Also, the insurance coverage for proton therapy has been improved. Proton
therapy is now covered by Medicare, and nearly all healthcare insurance providers. These services
have increased the convenience of patient's in managing high costs of the treatment.
The report, "US Proton Therapy Market Forecast to 2022" covers the current and future analysis of
US proton therapy market. Furthermore, analysis of the existing and upcoming proton therapy
centers in the US, along with an estimation of the shortage of proton centers in the current and
future scenario is also provided, which is intended to help players extract benefits from the largely
untapped but lucrative proton therapy market.
View summary of this report @ http://www.radiantinsights.com/research/us-proton-
therapy-market-forecast-to-2022
Follow Us: